BIO-TECHNE Corp Quarterly Other Liabilities, Noncurrent in USD from Q2 2014 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary: BIO-TECHNE Corp quarterly Other Liabilities, Noncurrent history and growth rate from Q2 2014 to Q1 2025.
BIO-TECHNE Corp Other Liabilities, Noncurrent for the quarter ending March 31, 2025 was $15.7M, a 35.5% increase year-over-year.

Other Liabilities, Noncurrent, Quarterly (USD)

Other Liabilities, Noncurrent, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$15.7M	+$4.1M	+35.5%	Mar 31, 2025	10-Q	2025-05-08
Q4 2024	$11.3M	-$6.02M	-34.7%	Dec 31, 2024	10-Q	2025-02-06
Q3 2024	$19.8M	+$10.4M	+111%	Sep 30, 2024	10-Q	2024-11-05
Q2 2024	$13.2M	+$2.24M	+20.5%	Jun 30, 2024	10-Q	2025-05-08
Q1 2024	$11.6M	+$584K	+5.32%	Mar 31, 2024	10-Q	2024-05-06
Q4 2023	$17.4M	+$6.03M	+53.1%	Dec 31, 2023	10-Q	2024-02-07
Q3 2023	$9.39M	-$2.11M	-18.3%	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$10.9M	-$1.32M	-10.8%	Jun 30, 2023	10-K	2024-08-22
Q1 2023	$11M	-$1.8M	-14.1%	Mar 31, 2023	10-Q	2023-05-08
Q4 2022	$11.3M	-$411K	-3.5%	Dec 31, 2022	10-Q	2023-02-07
Q3 2022	$11.5M	-$8.55M	-42.6%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$12.2M	-$12.2M	-50%	Jun 30, 2022	10-K	2023-08-23
Q1 2022	$12.8M	-$11M	-46.4%	Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$11.7M	-$14M	-54.5%	Dec 31, 2021	10-Q	2022-02-07
Q3 2021	$20M	-$9.94M	-33.1%	Sep 30, 2021	10-Q	2021-11-08
Q2 2021	$24.5M	-$2.49M	-9.23%	Jun 30, 2021	10-K	2022-08-24
Q1 2021	$23.8M	-$4.24M	-15.1%	Mar 31, 2021	10-Q	2021-05-07
Q4 2020	$25.8M	+$5.09M	+24.6%	Dec 31, 2020	10-Q	2021-02-08
Q3 2020	$30M	+$7.53M	+33.5%	Sep 30, 2020	10-Q	2020-11-09
Q2 2020	$26.9M	+$1.73M	+6.85%	Jun 30, 2020	10-K	2021-08-25
Q1 2020	$28.1M	+$8.56M	+43.9%	Mar 31, 2020	10-Q	2020-05-11
Q4 2019	$20.7M	+$2.71M	+15.1%	Dec 31, 2019	10-Q	2020-02-06
Q3 2019	$22.5M	+$12.8M	+132%	Sep 30, 2019	10-Q	2019-11-06
Q2 2019	$25.2M	+$15.9M	+170%	Jun 30, 2019	10-K	2020-08-26
Q1 2019	$19.5M	+$10.4M	+113%	Mar 31, 2019	10-Q	2019-05-07
Q4 2018	$18M	+$8.67M	+93%	Dec 31, 2018	10-Q	2019-02-07
Q3 2018	$9.67M	+$3.42M	+54.6%	Sep 30, 2018	10-Q	2018-11-07
Q2 2018	$9.34M	+$3.94M	+72.8%	Jun 30, 2018	10-K/A	2019-11-06
Q1 2018	$9.14M	+$4.74M	+108%	Mar 31, 2018	10-Q	2018-05-09
Q4 2017	$9.32M	+$5.69M	+157%	Dec 31, 2017	10-Q	2018-02-08
Q3 2017	$6.26M	+$2.6M	+71.2%	Sep 30, 2017	10-Q	2017-11-09
Q2 2017	$5.4M	+$2.09M	+62.9%	Jun 30, 2017	10-K	2018-08-27
Q1 2017	$4.4M	+$1.23M	+39%	Mar 31, 2017	10-Q	2017-05-10
Q4 2016	$3.63M	+$408K	+12.7%	Dec 31, 2016	10-Q	2017-02-09
Q3 2016	$3.65M	+$508K	+16.1%	Sep 30, 2016	10-Q	2016-11-09
Q2 2016	$3.32M	+$113K	+3.53%	Jun 30, 2016	10-K	2017-09-07
Q1 2016	$3.16M	+$1.02M	+47.6%	Mar 31, 2016	10-Q	2016-05-10
Q4 2015	$3.22M	+$1.32M	+69.8%	Dec 31, 2015	10-Q	2016-02-09
Q3 2015	$3.15M	+$2.44M	+344%	Sep 30, 2015	10-Q	2015-11-09
Q2 2015	$3.2M	+$3.2M		Jun 30, 2015	10-K	2016-08-29
Q1 2015	$2.14M			Mar 31, 2015	10-Q	2015-05-11
Q4 2014	$1.9M			Dec 31, 2014	10-Q	2015-02-09
Q3 2014	$708K			Sep 30, 2014	10-Q	2014-11-10
Q2 2014	$0			Jun 30, 2014	10-K	2015-08-31

Previous1Next

Showing 1 to 44 of 44 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.